Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
Bryan Q. Spring(Northeastern University), Tayyaba Hasan(Harvard University), Xiang Zheng(North University of China), Sriram Anbil(Massachusetts General Hospital), Ruth Goldschmidt(California Institute of Technology), Lawrence B. Mensah(Harvard University), R. Bryan Sears(Harvard University), Esther Oliva(Agostino Gemelli University Polyclinic), Adnan O. Abu‐Yousif(Takeda (Japan)), Zhiming Mai(MGH Institute of Health Professions), Akilan Palanisami(Harvard University), S. Sibel Erdem(Harvard University), Imran Rizvi(King George's Medical University)
Cited by 131
Related Papers
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy
|Theranostics|2016|432
Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
|The Journal of Pathology|2019|401
Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
|British Journal of Cancer|2014|388
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
|Journal of Nanobiotechnology|2020|327
Renal Cell Carcinoma in Tuberous Sclerosis Complex
|The American Journal of Surgical Pathology|2014|274